The organizing committee is pleased to announce that the 4th BelTox Workshop on Non-clinical Safety Assessment of Biopharmaceuticals will take place on Friday 16 October 2015 at Ablynx, Ghent, Belgium.
The topic of this year’s meeting will be the Development of bi-specific monoclonal antibodies and antibody-drug conjugates (ADCs). The preliminary programme is now available. The format of the workshop will be similar to the previous ones; i.e. lectures by international experts in the morning and the analysis of case studies in round table discussions in the afternoon, followed by a general discussion with the audience to foster interactions.
We would be delighted to meet you at this event. Registration is now open on the BelTox website and will be on first come-first served basis since the number of participants is limited to 70. Registration fees, including coffees breaks and lunch, are 250 € for BelTox members and 400 € for non-members.
The registration deadline is October 2nd 2015.
We are convinced the workshop will provide again a unique opportunity for networking and to follow up on recent advances in biopharmaceutical drug development.
We already look forward to meeting you at the workshop!
Miranda Cornet, on behalf of the Organising Committee
To download the program, the itinerary or the list of recommended hotels, please use the attachments below: